4//SEC Filing
Apelian David 4
Accession 0001209191-21-020572
CIK 0001305253other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:22 PM ET
Size
7.2 KB
Accession
0001209191-21-020572
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Common Stock
2021-03-12+5,000→ 10,000 total - Award
Stock Option (Right to Buy)
2021-03-12+10,000→ 10,000 totalExercise: $9.99Exp: 2031-03-11→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2021.
- [F2]The option vests in equal monthly installments over 12 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001546842
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:22 PM ET
- Size
- 7.2 KB